Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut microbiome and host-microbiota interface represent a complex biological system comprising trillions of microorganisms that coexist with the human host. This ecosystem performs vital functions, including the fermentation of complex carbohydrates into short-chain fatty acids, the synthesis of vitamins, and the education of the host immune system (Nature Reviews Microbiology, 2020). It also maintains the intestinal barrier and provides colonization resistance against pathogens like Clostridioides difficile (NIH, 2023). Dysbiosis, or the disruption of this microbial balance, is implicated in various conditions such as inflammatory bowel disease, obesity, and metabolic syndrome (Cell, 2021). Unlike traditional drug targets, this interface is modulated through ecosystem-level interventions such as fecal microbiota transplantation (FMT), probiotics, and prebiotics rather than single-molecule inhibitors (FDA, 2023). Recent therapeutic advancements include standardized bacterial consortia designed to restore ecological diversity and resolve recurrent infections (Nature Medicine, 2022).
Restoration of microbial diversity and ecological balance to inhibit pathogen colonization, produce beneficial metabolites like short-chain fatty acids, and modulate host immune and metabolic pathways (Nature Reviews Microbiology, 2020).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiome and host-microbiota interface.